Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...

The packaging of the medication is considered not child-resistant because a tablet can be pushed through the foil, posing a ...

More than 14,000 packs of ‘cough, cold & flu’ medicine are being recalled over a risk of child poisoning, according to the ...